Reference ranges
Optimal ranges are tighter than standard lab ranges and reflect functional-medicine targets, not the populations they were derived from. Reference bands depend on sex, age, and circumstance — Juno's lab analysis layers your profile context onto the printed range when you paste a value.
Peptide relevance
BPC-157 + TB-500 have no documented effect on testosterone in human studies. CJC-1295 + Ipamorelin (GHRP) modestly raise IGF-1 but no consistent testosterone effect. Tesamorelin is a GHRH analog (IGF-1 axis, not HPG axis). Tirzepatide / Semaglutide (GLP-1) — modest fat loss can raise free testosterone in men with obesity; total T effect is variable. Direct exogenous testosterone (TRT) elevates total T and may suppress LH/FSH; not a peptide. Range above is for adult males 30-49; adult females and older men have different reference bands.
Peptides that influence this marker
Documented to affect this marker. Click through for the full evidence-tiered profile.
- KisspeptinKISS1R agonist (hypothalamic neuropeptide)
Stimulates GnRH → LH/FSH → endogenous testosterone production
- RetatrutideGLP-1 / GIP / glucagon triple agonist
Significant fat loss may modestly raise free testosterone in men with obesity
- SemaglutideGLP-1 receptor agonist
Fat loss in obesity can modestly raise free testosterone; total T effect variable
- TirzepatideGLP-1 / GIP dual agonist
Fat loss in obesity can modestly raise free testosterone; total T effect variable
Have a recent Testosterone, total value?
Paste it on the lab analysis page. Juno reads your active stack + (if shared) your medications and conditions, and surfaces plausible contributors with citations. Doesn't diagnose.
Sign-in required. The analysis is saved to your private history and audit-logged.